Time Window for Ischemic Stroke First Mobilization Effectiveness

Status Recruiting

Clinical Trial Summary

Early mobilization was thought to be effective in patients with acute ischemic stroke. As the essential component of stroke unit care, early mobilization has already been part of routine clinical practice. However, it is uncertain that which and when medical service focusing on functional recovery should be delivered after the emergency interventions for stroke. Besides, the optimal time window, for delivering early mobilization after acute ischemic stroke, has not been verified with strong evidence.

Clinical Trial Description

The TIME Trial is a pragmatic, investigator-initiated, multi-center, randomized, 3-arm parallel group, clinical trial. This trial will be conducted in 57 general hospitals in mainland China affiliated with the China Stroke Databank Center and will enroll 6033 eligible patients with acute ischemic stroke. Participants will be randomly allocated to either (1) the very early mobilization group in whichmobilization is initiated within 24 hours from stroke onset, (2) the early mobilization group in which mobilization begins between 24 and 72 hours poststroke, or (3) the late mobilization group in which mobilization is started after 72 hours poststroke. The mobilization protocol is otherwise standardized and identical for each comparison group. Mobilization is titrated by baseline mobility level and progress of patients throughout the intervention period. The primary outcome is death or disability assessed with the modified Rankin scale at 3 months poststroke. Secondary outcomes include impairment score of the National Institutes of Health Stroke Scale, dependence in activities of daily living as measured using the modified Barthel Index, cognitive ability assessed with the Mini-Mental State Examination, incidence of adverse events, hospital length of stay, and total medical costs. Study design: an Investigator-Initiated Prospective Multicenter Randomized 3-Arm Clinical Trial Sample size: 1500 cases ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03938311
Study type	Interventional
Source	China Stroke Databank Center
Contact	Lu Xiao, MD/PHD
Phone	+86 025-83718836
Email	luxiao1972@163.com
Status	Recruiting
Phase	N/A
Start date	August 13, 2019
Completion date	December 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05131295` - Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.	Phase 3
Completed	`NCT01915368` - Determining Optimal Post-Stroke Exercise (DOSE)	N/A
Completed	`NCT01955642` - Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke	N/A
Recruiting	`NCT01541163` - Heart and Ischemic STrOke Relationship studY	N/A
Recruiting	`NCT06076122` - Salicornia for Neurovascular Health Improve	N/A
Not yet recruiting	`NCT04386525` - Omega 3 and Ischemic Stroke; Fish Oil as an Option	Phase 4
Recruiting	`NCT06270927` - A Feasibility Study for Randomization of Code Stroke Imaging Strategies
Completed	`NCT02912546` - Cerebral Perfusion Associated With Postural Changes: an ASL MR Perfusion Study	N/A
Completed	`NCT02684825` - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke	N/A
Completed	`NCT05815836` - Precision Medicine in Stroke
Recruiting	`NCT01673932` - Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke	Phase 1
Recruiting	`NCT01556802` - Use of Minocicline in Patients With Stroke	Phase 1
Completed	`NCT02101606` - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke	Phase 2
Completed	`NCT00829361` - Stroke Telemedicine for Arizona Rural Residents Trial	N/A
Terminated	`NCT00073372` - A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)	Phase 3
Recruiting	`NCT04908241` - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT)	N/A
Recruiting	`NCT04188132` - EEG Based BCI for Upper Limb Rehabilitation in Stroke	N/A
Completed	`NCT01713491` - Pre-stroke Cognitive Status and Thrombolytic Therapy	N/A
Completed	`NCT01443962` - The Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy	N/A
Terminated	`NCT01059149` - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup)	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Time Window for Ischemic Stroke First Mobilization Effectiveness — TIME

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms